Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Real-time Estimate Cboe BZX
Other stock markets
 10:22:34 2024-07-09 am EDT 		5-day change 1st Jan Change
0.296 USD +1.79% Intraday chart for Galmed Pharmaceuticals Ltd. +4.03% -34.77%
May. 30 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Galmed Pharmaceuticals Ltd.

1da9fac5e16.yoCmXs84gJ2fIDqNG_x95q2yQ_DtMGe4lVyHmjAUylM.hPThZvh92u6vdFzLSJEukMrae7K5Zzbp3y729AcjlRGl94sd_G3h9ttQew~bb925be91eae4380ae8f7230355eeb2c

Upcoming events on Galmed Pharmaceuticals Ltd.

2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on Galmed Pharmaceuticals Ltd.

2023-06-20 09:00 am Maxim Group Virtual Healthcare Conference
2023-06-01 08:00 am Q1 2023 Earnings Release
2023-05-04 10:00 am Annual General Meeting
2022-08-04 08:00 am Interim 2022 Earnings Release
2022-05-17 08:00 am Q1 2022 Earnings Release
2022-05-02 08:30 am FY 2021 Earnings Call
2022-05-02 07:00 am FY 2021 Earnings Release
2021-11-11 AASLD The Liver Meeting
2021-11-08 08:30 am Q3 2021 Earnings Call - ARMOR Phase 3 Study Update
2021-11-08 07:30 am Q3 2021 Earnings Release
2021-08-05 08:30 am Interim 2021 Earnings Call
2021-08-05 07:00 am Interim 2021 Earnings Release
2021-05-13 08:30 am Q1 2021 Earnings Call
2021-05-13 07:50 am Q1 2021 Earnings Release
2021-03-18 08:30 am FY 2020 Earnings Call
2021-03-18 07:00 am FY 2020 Earnings Release
2020-11-18 08:00 am Stifel Healthcare Conference
2020-11-12 08:30 am Q3 2020 Earnings Call
2020-11-12 07:00 am Q3 2020 Earnings Release
2020-08-06 08:30 am Interim 2020 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-20,1
-20,0
-0.55%		-28,1
-23,3
-20.62%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-22,4
-21,6
-3.78%		-30,2
-27,7
-9.15%		-32,9
-34,2
3.75%		-17,7
-18,9
6.43%		-7,49
-8,20
8.6%
-10,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-20,5
-19,8
-3.27%		-28,8
-26,2
-9.61%		-32,5
-33,6
3.28%		-17,9
-18,9
5.32%		-6,91
-7,75
10.78%
-10,6

Net income
Million USD		Released
Forecast
Spread 		-20,5
-19,8
-3.27%		-28,8
-26,2
-9.61%		-32,5
-33,5
3.11%		-17,9
-18,9
5.32%		-6,91
-7,75
10.78%
-10,6

EPS
USD		Released
Forecast
Spread 		-14,5
-14,1
-3.47%		-20,2
-18,6
-9.05%		-19,8
-19,8
0.15%		-10,6
-11,2
5.33%		-2,50
-2,63
4.94%
-1,29

Announcement Date12/03/2018/03/2102/05/2229/03/2304/04/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-6,09
-8,27
26.36%		-3,73
-6,56
43.11%		-5,38
-4,19
-28.32%		-2,45
-3,66
33.11%		-2,00
-2,50
19.86%		-1,87
-2,04
8.37%		-1,47
-1,97
25.6%		-2,15
-2,35
8.51%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,14
-8,25
25.56%		-3,37
-6,54
48.39%		-5,35
-4,16
-28.54%		-2,64
-3,64
27.54%		-1,83
-2,50
26.74%		-1,59
-2,04
21.99%		-1,47
-1,97
25.34%		-2,02
-2,35
14.25%
Net income
Million USD		Released
Forecast
Spread 		-6,14
-8,25
25.56%		-3,37
-6,54
48.39%		-5,35
-4,16
-28.54%		-2,64
-3,64
27.54%		-1,83
-2,50
26.74%		-1,59
-2,04
21.99%		-1,47
-1,97
25.34%		-2,02
-2,35
14.25%
EPS
USD		Released
Forecast
Spread 		-3,60
-4,80
25%		-2,25
-3,54
36.44%		-3,15
-2,48
-27.27%		-1,50
-2,10
28.57%		-1,09
-1,50
27.33%		-0,95
-0,34
-179.41%		-0,24
-0,27
11.11%		-0,22
-0,32
31.25%
Announcement Date17/05/2204/08/2216/11/2229/03/2301/06/2309/08/2322/11/2304/04/24

Upcoming sector events for Galmed Pharmaceuticals Ltd.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Galmed Pharmaceuticals Ltd.

2024-06-05 03:51 am PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. Calendar Galmed Pharmaceuticals Ltd.